These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 24114694

  • 1. Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets.
    Federman N, Brien EW, Narasimhan V, Dry SM, Sodhi M, Chawla SP.
    Paediatr Drugs; 2014 Feb; 16(1):21-8. PubMed ID: 24114694
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T, Kawashima H, Ogose A, Ariizumi T, Sasaki T, Hatano H, Hotta T, Endo N.
    PLoS One; 2016 Feb; 11(5):e0154680. PubMed ID: 27163152
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Denosumab Induces Neoplastic Stromal Cell Apoptosis Via p62 Downregulation Dependent on Autophagy Pathway in Giant Cell Tumour of Bone.
    Chen X, Ye F, He H, Chen G, Chen Z, Ye E, He B, Yang Y, Zhang J.
    Curr Cancer Drug Targets; 2024 Feb; 24(5):565-578. PubMed ID: 37961860
    [Abstract] [Full Text] [Related]

  • 9. RANKL, denosumab, and giant cell tumor of bone.
    Thomas DM.
    Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
    [Abstract] [Full Text] [Related]

  • 10. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.
    Lipplaa A, Dijkstra S, Gelderblom H.
    Curr Opin Oncol; 2019 Jul; 31(4):329-335. PubMed ID: 30844887
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.
    Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU.
    Ann Diagn Pathol; 2020 Apr; 45():151479. PubMed ID: 32088577
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Denosumab: Excellent response of metastatic giant cell tumor of the bone.
    Ulas A, Bulent Akinci M, Silay K, Sendur MA, Sener Dede D, Yalcin B.
    J BUON; 2015 Apr; 20(2):666-7. PubMed ID: 26011370
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 18. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
    Reddy K, Ramirez L, Kukreja K, Venkatramani R.
    J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e215-e218. PubMed ID: 31714440
    [Abstract] [Full Text] [Related]

  • 19. Denosumab for the treatment of bone metastases in advanced breast cancer.
    Casas A, Llombart A, Martín M.
    Breast; 2013 Oct 01; 22(5):585-92. PubMed ID: 23759273
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
    Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, Schuetze S, Skubitz K, Staddon A, Thomas D, Qian Y, Jacobs I.
    Lancet Oncol; 2013 Aug 01; 14(9):901-8. PubMed ID: 23867211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.